Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - AVANIR PHARMACEUTICALS, INC. | a54399e10vk.htm |
| EX-32.2 - EX-32.2 - AVANIR PHARMACEUTICALS, INC. | a54399exv32w2.htm |
| EX-31.2 - EX-31.2 - AVANIR PHARMACEUTICALS, INC. | a54399exv31w2.htm |
| EX-31.1 - EX-31.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv31w1.htm |
| EX-32.1 - EX-32.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv32w1.htm |
| EX-21.1 - EX-21.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv21w1.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-83089, 333-84183,
333-38094, 333-108716, 333-125743, 333-144221, 333-150253 and 333-158595 on Form S-8 and
Registration Statements No. 333-158665, 333-161789, 333-149125 and 333-34958 on Form S-3 of our
report dated November 25, 2009, relating to the consolidated financial statements of
Avanir Pharmaceuticals, Inc. and subsidiaries appearing in this Annual Report on Form 10-K
of Avanir Pharmaceuticals, Inc. for the year ended September 30, 2009.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
November 25, 2009
November 25, 2009